Characterization of Nanoparticles Intended for Drug Delivery /

Bibliographic Details
Corporate Author: SpringerLink (Online service)
Other Authors: McNeil, Scott E. (Editor)
Format: eBook
Language:English
Published: New York, NY : Springer New York : Imprint: Humana, 2018.
Edition:2nd ed. 2018.
Series:Methods in Molecular Biology, 1682
Subjects:
Table of Contents:
  • Evaluating Nanomedicines: Obstacles and Advancements
  • Detection of Bacterial Contamination in Nanoparticle Formulations by Agar Plate Test
  • Considerations and Some Practical Solutions to Overcome Nanoparticle Interference with LAL Assays and to Avoid Endotoxin Contamination in Nanoformulations
  • Elemental Analysis in Biological Matrices Using ICP-MS
  • PEG Quantitation Using Reversed Phase High Performance Liquid Chromatography and Charged Aerosol Detection
  • Quantitation of Surface Coating on Nanoparticles Using Thermogravimetric Analysis
  • Immunoelectron Microscopy for Visualization of Nanoparticles
  • Imaging of Liposomes by Transmission Electron Microscopy
  • Updated Method for In Vitro Analysis of Nanoparticle Hemolytic Properties
  • In Vitro Assessment of Nanoparticle Effects on Blood Coagulation
  • In Vitro Analysis of Nanoparticle Effects on the Zymosan Uptake by Phagocytic Cells
  • Assessing NLRP3 Inflammasome Activation by Nanoparticles
  • Analysis of Complement Activation by Nanoparticles
  • Methods for Analysis of Nanoparticle Immunosuppressive Properties In Vitro and In Vivo
  • Analysis of Pro-Inflammatory Cytokine and Type II Interferon Induction by Nanoparticles
  • Analysis of Nanoparticle Adjuvant Properties In Vivo
  • In Vitro and In Vivo Methods for Analysis of Nanoparticle Potential to Induce Delayed Type Hypersensitivity Reactions
  • Autophagy Monitoring Assay II: Imaging Autophagy Induction in LLC-PK1 Cells Using GFP-LC3 Protein Fusion Construct
  • Improved Ultrafiltration Method to Measure Drug Release from Nanomedicines Utilizing a Stable Isotope Tracer
  • Designing an In Vivo Efficacy Study of Nanomedicines for Preclinical Tumor Growth Inhibition.